Observer-masked trial comparing efficacy of topical olopatadine (0.1 & #37;), bepotastine (1.5 & #37;), and alcaftadine (0.25 & #37;) in mild to moderate allergic conjunctivitis

Conclusion: We concluded similar efficacy of three medications in relieving symptoms and inefficacy in regressing palpebral and limbal papillae in cases of allergic conjunctivitis.
Source: Indian Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research